Gaeta ex rel. A.G. v. Perrigo Pharmaceuticals Co.

469 F. App'x 556
Court of Appeals for the Ninth Circuit·Decided February 27, 2012·No. No. 09-15001·Published·Cited by 10 cases

Opinion

ORDER

The Supreme Court having vacated our prior opinion for farther consideration in light of PLIVA, Inc. v. Mensing, — U.S. -, 131 S.Ct. 2567, 180 L.Ed.2d 580 (2011), see L. Perrigo Co. v. Gaeta, — U.S.-, 132 S.Ct. 497, 181 L.Ed.2d 343 (2011), we now AFFIRM the district court’s grant of summary judgment in favor of Perrigo Pharmaceuticals Company.

Free access — add to your briefcase to read the full text and ask questions with AI

Gaeta ex rel. A.G. v. Perrigo Pharmaceuticals Co., 469 F. App'x 556 (9th Cir. 2012).

469 F. App'x 556 (Gaeta ex rel. A.G. v. Perrigo Pharmaceuticals Co.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Greager v. McNeil PPC, Inc.
N.D. Illinois, 2019
Moore v. Zydus Pharmaceuticals (USA), Inc.
277 F. Supp. 3d 873 (E.D. Kentucky, 2017)
Stephens v. Teva Pharmaceuticals, U.S.A., Inc.
70 F. Supp. 3d 1246 (N.D. Alabama, 2014)
Schrock v. Wyeth Inc.
Tenth Circuit, 2013
Teva Pharmaceuticals USA, Inc. v. Superior Court
217 Cal. App. 4th 96 (California Court of Appeal, 2013)